Compare Becton Dickinson and Co (BDX) vs iShares Bitcoin Trust (IBIT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs iShares Bitcoin Trust — how do they compare? Becton Dickinson and Co trades at $154.29 (market cap $41.51B), while iShares Bitcoin Trust trades at $36.69. The key difference: Becton Dickinson and Co pays a 2.79% dividend while iShares Bitcoin Trust pays none, and Becton Dickinson and Co is trading nearer its 52-week high, iShares Bitcoin Trust nearer its low. Which is the better fit depends on your goals.
| BDX | IBIT | |
|---|---|---|
Market Cap | $41.51B | — |
Sector | Health | Crypto-linked |
52-Week High | $185.39 | $71.29 |
52-Week Low | $135.49 | $33.29 |
Enterprise Value | $57.97B | — |
Dividend Yield | 2.79% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX trades at $153.83, up 1.24% today, with technical indicators showing a neutral to bullish bias. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $2.90 exceeding expectations. Revenue growth remains steady, reaching $21.84B in 2025, though net margins have compressed to 5.12%. Recent news highlights BDX's innovation in medical technology and positive analyst sentiment.
The outlook for BDX appears balanced. Upside potential exists from continued earnings beats and strategic positioning in growing healthcare segments like GLP-1 drug support equipment. However, risks include margin pressure, elevated debt levels, and cautious hospital spending. The consensus price target of $173.40 suggests moderate upside from current levels.
IBIT trades at $35.22, down 2.79% today, reflecting recent bearish pressure. Technical indicators show a predominantly bearish trend with moving averages signaling sell conditions, while oscillators remain neutral. The stock faces resistance at $36 and finds support at $35. Recent news highlights IBIT's position as a leading Bitcoin ETF with $44.9 billion in assets under management, surpassing competitors like Fidelity's offering as of June 29, 2026 (The Motley Fool).
The outlook for IBIT hinges on Bitcoin ETF flows and market sentiment toward crypto assets. Investment opportunities include its dominant market share and low expense ratio, but risks involve significant outflows from Bitcoin ETFs, with a record $4.5 billion in June 2026 (Zacks Investment Research, July 6, 2026), and volatility linked to cryptocurrency price swings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About iShares Bitcoin Trust
IBIT is a spot Bitcoin ETF that tracks the price of Bitcoin directly. Managed by BlackRock, it offers investors a regulated way to gain exposure to the digital asset within a traditional brokerage account.
Read more on IBIT →
